Skip to main content
. 2023 Feb 13;14:1034865. doi: 10.3389/fneur.2023.1034865

Table 4.

Characteristics of all patients with or without gastrointestinal bleeding after PSM.

Characteristics Non-GI bleeding
(N = 64)
GI bleeding
(N = 64)
Univariate
P value
Age, median (IQR), yrs 57.5 (49.5–65.75) 65.0 (56.0–71.75) 0.004
Gender 1.000
Male (N, %) 41 (64.1) 41 (64.1)
Female (N, %) 23 (35.9) 23 (35.9)
Medical history
Smoking (N, %) 4 (6.3) 7 (10.9) 0.344
Alcohol (N, %) 5 (7.8) 8 (12.5) 0.388
Hypertension (N, %) 41 (64.1) 48 (75.0) 0.179
Diabetes mellitus (N, %) 9 (14.1) 13 (20.3) 0.349
Prior anticoagulation or antiplatelet therapy (N, %) 13 (20.3) 7 (10.9) 0.144
Time from symptom onset to initial CT, hours, median (IQR) 4.0 (3.0–5.0) 4.0 (3.0–5.0) 0.296
Baseline GCS score, median (IQR) 11.0 (8.25–14.0) 9.0 (7.0–11.0) < 0.001
Baseline volume (N, %) 0.375
< 30 ml 37 (57.8) 32 (50.0)
≥30 ml 27 (42.2) 32 (50.0)
ICH location (N, %) 0.004
Deep 34 (53.1) 52 (81.3)
Lobar 22 (34.4) 8 (12.5)
Brain stem 3 (4.7) 0 (0.0)
Cerebellum 5 (7.8) 4 (6.3)
Intraventricular hemorrhage (N, %) 13 (20.3) 13 (20.3) 1.000
Hemoglobin (g/L) 150.0 (141.0–164.0) 148.0 (136.0–169.0) 0.625
Coagulation function, median (IQR)
Platelets (109/L) 173.50 (142.00–201.75) 162.50 (129.25–190.25) 0.287
aPTT, s 26.35 (22.33–30.03) 25.70 (22.00–30.70) 0.786
INR 1.02 (0.97–1.02) 1.03 (0.95–1.09) 0.784
Prothrombin time, s 11.70 (11.00–12.20) 11.45 (10.90–12.00) 0.289
Fibrinogen, g/L 2.78 (2.30–3.49) 2.90 (2.27–3.47) 0.545
Thrombin time, s 17.35 (15.13–18.70) 17.0 (14.60–18.90) 0.324
MV used >48 h (N, %) 22 (34.4) 23 (35.9) 0.853
Surgery (N, %) 36 (56.3) 41 (64.1) 0.367
AGR, median (IQR) 5.24 (4.24–6.40) 7.47 (5.38–9.32) < 0.001
Modified Rankin Scale (N, %) < 0.001
0–2 47 (73.4) 16 (25.0)
3–6 17 (26.6) 48 (75.0)

AGR, age-to-GCS ratio; aPTT, activated partial thromboplastin time; CT, computed tomography; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; INR, international normalized ratio; IQR, interquartile range; PSM, propensity score matching.